BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1720 related articles for article (PubMed ID: 15224208)

  • 1. Evaluation of insulin release and insulin sensitivity through oral glucose tolerance test: differences between NGT, IFG, IGT, and type 2 diabetes mellitus. A cross-sectional and follow-up study.
    Pontiroli AE; Pizzocri P; Caumo A; Perseghin G; Luzi L
    Acta Diabetol; 2004 Jun; 41(2):70-6. PubMed ID: 15224208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the U.S.
    Jensen CC; Cnop M; Hull RL; Fujimoto WY; Kahn SE;
    Diabetes; 2002 Jul; 51(7):2170-8. PubMed ID: 12086947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin secretion and insulin sensitivity in diabetic subgroups: studies in the prediabetic and diabetic state.
    Tripathy D; Carlsson AL; Lehto M; Isomaa B; Tuomi T; Groop L
    Diabetologia; 2000 Dec; 43(12):1476-83. PubMed ID: 11151756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Insulin secretion and insulin sensitivity in 1193 inpatients with essential hypertension].
    Tang XF; Li H; Wang JG; Chu SL; Guo JZ; Zhu DL
    Zhonghua Nei Ke Za Zhi; 2004 Oct; 43(10):735-9. PubMed ID: 15631823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin sensitivity and secretion in Arab Americans with glucose intolerance.
    Salinitri FD; Pinelli NR; Martin ET; Jaber LA
    Diabetes Technol Ther; 2013 Dec; 15(12):1019-24. PubMed ID: 23919587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose.
    Kanat M; Norton L; Winnier D; Jenkinson C; DeFronzo RA; Abdul-Ghani MA
    Acta Diabetol; 2011 Sep; 48(3):209-17. PubMed ID: 21553243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study.
    Bianchi C; Miccoli R; Trombetta M; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Cavalot F; Cavallo G; Leonetti F; Bonadonna RC; Del Prato S;
    J Clin Endocrinol Metab; 2013 May; 98(5):2100-5. PubMed ID: 23539736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study.
    Tripathy D; Carlsson M; Almgren P; Isomaa B; Taskinen MR; Tuomi T; Groop LC
    Diabetes; 2000 Jun; 49(6):975-80. PubMed ID: 10866050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels.
    Utzschneider KM; Prigeon RL; Faulenbach MV; Tong J; Carr DB; Boyko EJ; Leonetti DL; McNeely MJ; Fujimoto WY; Kahn SE
    Diabetes Care; 2009 Feb; 32(2):335-41. PubMed ID: 18957530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in insulin action and secretion, plasma lipids and blood pressure levels between impaired fasting glucose and impaired glucose tolerance in Japanese subjects.
    Miyazaki Y; Akasaka H; Ohnishi H; Saitoh S; DeFronzo RA; Shimamoto K
    Hypertens Res; 2008 Jul; 31(7):1357-63. PubMed ID: 18957806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Insulin sensitivity and beta function in the first-degree relatives of type 2 diabetic patients].
    Han XY; Ji LN; Zhou XH
    Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1777-80. PubMed ID: 15631772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of future diabetes is as high with abnormal intermediate post-glucose response as with impaired glucose tolerance.
    Viswanathan V; Clementina M; Nair BM; Satyavani K
    J Assoc Physicians India; 2007 Dec; 55():833-7. PubMed ID: 18405128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of glucose tolerance in impaired glucose tolerance at baseline in the Actos Now for Prevention of Diabetes (ACT NOW) study.
    DeFronzo RA; Banerji MA; Bray GA; Buchanan TA; Clement S; Henry RR; Kitabchi AE; Mudaliar S; Musi N; Ratner R; Reaven P; Schwenke DC; Stentz FD; Tripathy D;
    Diabetologia; 2010 Mar; 53(3):435-45. PubMed ID: 20012012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans.
    Meyer C; Pimenta W; Woerle HJ; Van Haeften T; Szoke E; Mitrakou A; Gerich J
    Diabetes Care; 2006 Aug; 29(8):1909-14. PubMed ID: 16873801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance and systemic metabolic changes in oral glucose tolerance test in 5340 individuals: an interventional study.
    Wang Q; Jokelainen J; Auvinen J; Puukka K; Keinänen-Kiukaanniemi S; Järvelin MR; Kettunen J; Mäkinen VP; Ala-Korpela M
    BMC Med; 2019 Nov; 17(1):217. PubMed ID: 31779625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired fasting glycaemia vs impaired glucose tolerance: similar impairment of pancreatic alpha and beta cell function but differential roles of incretin hormones and insulin action.
    Faerch K; Vaag A; Holst JJ; Glümer C; Pedersen O; Borch-Johnsen K
    Diabetologia; 2008 May; 51(5):853-61. PubMed ID: 18317726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Characteristics of glycemic excursion in different subtypes of impaired glucose intolerance].
    Kang Y; Lu JM; Sun JF; Li CL; Wang XL; Zhang XQ; Lü ZH; Dou JT; Mu YM
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):669-72. PubMed ID: 19595059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study.
    Abdul-Ghani MA; Jenkinson CP; Richardson DK; Tripathy D; DeFronzo RA
    Diabetes; 2006 May; 55(5):1430-5. PubMed ID: 16644701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited value of the homeostasis model assessment to predict insulin resistance in older men with impaired glucose tolerance.
    Ferrara CM; Goldberg AP
    Diabetes Care; 2001 Feb; 24(2):245-9. PubMed ID: 11213873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal glycemic profiles by CGMS in obese first-degree relatives of type 2 diabetes mellitus patients.
    Madhu SV; Muduli SK; Avasthi R
    Diabetes Technol Ther; 2013 Jun; 15(6):461-5. PubMed ID: 23631606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 86.